Therapeutic binding molecule that binds to CCR9

PH12023552430B1Active Publication Date: 2026-09-04MEDIMMUNE LTD

0 Cites 0 Cited by

Patent Information

Application Number: PH12023552430
Authority / Receiving Office: PH · PH
Patent Type: Patents
Current Assignee / Owner
Filing Date: 2023-09-04
Publication Date: 2026-09-04
Estimated Expiration: 2043-09-04

Application Information

Patent Timeline

04 Sep 2023

Application

PH12023552430

04 Sep 2026

Publication

PH12023552430B1

Inventors: NYS, Josquin Arnaud; THOM, Albert George

Get more patent work done with AI

Run novelty searches—or use them for FTO, design risk, drafting and technical problem-solving.

Explore More Agents

Novelty Search
Search existing technologies and assess novelty
↗
FTO
Analyze whether a product may infringe others' patents
↗
Design FTO
Check prior-design risk for exterior design
↗
Drafting
Draft patent application text based on a technical solution
↗
Find Solutions with TRIZ
Generate feasible solution to solve your technical challenge
↗
IP MCP Servers
Connect trusted patent search and cited evidence to Claude, Cursor or your own AI workflow
↗

Patent Text Reader

Abstract

The invention relates to binding molecules, such as antibodies, that bind to the chemokine receptor CCR9. More particularly, the invention relates to the treatment of CCR9-mediated diseases or conditions such as inflammatory bowel disease (IBD), and methods for the detection of CCR9, which make use of the binding molecules of the invention.

Need to check novelty before this filing date? Find Prior Art